Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Focus of Study Instead × Afatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 21 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 9 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 NSCLC 2 Glioblastoma 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thoracic Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrence 1

Interventions

Gemcitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728818 2017-07-19

ACCEPT

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Focus of Study Instead

Data powered by HemOnc (CC BY 4.0) Colophon ⚡